The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital ...

Artificial intelligence is rapidly learning to autonomously design and run biological experiments, but the systems intended ...

The first-ever published research on Tinshemet Cave reveals that Neanderthals and Homo sapiens in the mid-Middle Paleolithic ...

More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

Replimune Group criticized a Food and Drug Administration decision to deny its application for a melanoma treatment in a review process that the clinical-stage biotechnology company said was marked by ...

How do neurons transport proteins? A new study reveals that Kinesin-2 motor subtypes regulate cargo specificity.

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to ...

(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...

It is only when driving through them that one senses the pulse of what has been widely referred to in China as "the city of the future." Here, drivers no longer "obey" green lights; the lights "obey" ...

Learn about the untapped power of biomimicry to transform business and the planet.